This Study Aims to Evaluate the Efficacy and Safety of QLS1317 in Patients With MSI-H/dMMR Advanced Solid Tumors.
Clinical trial NCT07552376 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07552376
- Sponsor
- Shanghai Qilu Pharmaceutical Research and Development Center LTD
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2028-06-01
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.